Milestone Scientific (NYSE:MLSS) said today that its CompuFlo epidural computer-controlled anesthesia system won 510(k) clearance from the FDA. The Livingston, N.J.-based company’s CompuFlo Epidural instrument uses dynamic pressure sensing to help anesthesiologists correctly identify the epidural space and significantly reduce complications in real-time, according to Milestone. Get the full story at our sister site, Drug […]
Neuromodulation/Neurostimulation
FDA asks Endo to pull Opana from the market over concerns of abuse
The FDA asked Endo Pharmaceuticals (NSDQ:ENDP) to pull its opioid pain med, Opana ER, from the market, saying that the benefits of the abuse-deterrent drug no longer outweigh the risks. The move marks the 1st time the federal regulatory watchdog has urged a company to remove an opioid painkiller due to concerns of abuse. Get the full […]
ElectroCore touts gammaCore cluster headache trial data
Neuroscience tech developer ElectroCore today released data from the ACT clinical trials exploring the use of its gammaCore non-invasive vagus nerve stimulator for treating patients with episodic cluster headaches. Results from the study were presented at the 59th Annual Scientific Meeting of the American Headache Society, the company said. The 250-patient studies evaluated the safety and efficacy of the […]
Nexeon registers for 5m unit shareholder offering
Neurostimulation device developer Nexeon Medsystems today announced an upcoming offering, in which 5.3 million shares will be offered by certain existing company shareholders. Nexeon produces a range of neurostimulation devices which use an implantable pulse generator and 2 connectors for electrode leads with up to 8 contacts each. The devices feature a custom chip designed […]
Boston Scientific wins CE Mark for Vercise Gevia DBS
Boston Scientific (NYSE:BSX) said today that it won CE Mark approval in the European Union for its Vercise Gevia deep-brain stimulation device for treating movement disorder symptoms. Marlborough, Mass.-based Boston Scientific said the new system features programming software called the Vercise Neural Navigator 2 with Stimview, designed to allow physicians to see images of the stimulation field while the […]
6 brain-controlled devices helping people regain movement
People who have lost feeling in their limbs or have lost the ability to move them may soon have those sensations restored thanks to a slew of recent brain-controlled device innovations. While we are moving toward less invasive methods like electrode-filled caps on the head, there are still more invasive implants that are benefiting those […]
Critics allege misleading campaigns, poorly-cited data fueled opioid addiction crisis
The state of Ohio filed a lawsuit against opioid-makers this week, alleging that the companies produced misleading marketing schemes to convince doctors and patients that opioids were not addictive. This was a huge problem throughout the state, everybody knows that it can be very addictive and that’s why it is important to get Ibogaine Treatment […]
BioElectronic launches migraine study for ActiPatch pulsed shortwave therapy
Non-invasive electroceutical developer BioElectronics said today it launched a clinical study of its ActiPatch, examining the use of the device for treating migraines. The ActiPatch is a series of patches or wraps which use electromagnetic pulse therapy to treat chronic pain, according to the Frederick, Md.-based company’s website. In the randomized, double-blinded placebo controlled study, […]
Mallinckrodt faces probe over price hikes for injectable pain-killer
Sen. Claire McCaskill (D-Mo.) penned a letter to Mallinckrodt Pharmaceuticals (NYSE:MNK) last week, probing for details about the company’s pricing strategies for its injectable pain-killer, Ofirmev. Mallinckrodt acquired Ofirmev in 2014, when it bought Cadence Pharmaceuticals in a $1.4 billion deal. In May of that year, Mallinckrodt hiked the pain-killer’s list price from $14.75 per vial to […]
Revive Therapeutics, University of Wisconsin-Madison ink deal for cannabinoid drug delivery tech
Revive Therapeutics (OTC:RVVTF) said today that it inked a research agreement with the University of Wisconsin-Madison to develop a drug delivery technology for cannibinoids. The research program, led by Jess Reed, is slated to evaluate chitosan-tannin composite biomaterial as a delivery mechanism for cannabinoids. Therapeutic biomaterials made from a composite of chitosan and tannin include […]
Medtronic increases stake in Saluda Medical
Saluda Medical said it raised nearly $40 million (A$53 million) for the Evoke closed-loop neuromodulation device it’s developing to treat axial back pain. The round was led by a new investor, GlaxoSmithKline‘s (NYSE:GSK) Action Potential Venture Capital, joined by existing backer Medtronic (NYSE:MDT), Artarmon, Australia- and Bloomington, Minn.-based Saluda said. The Evoke spinal cord stimulator is […]